Investors and partners are both key audiences for early stage biotechnology companies.  Furthermore, presenting the right message and image is critical in attracting money and deals.  321 Medical Launch partnered with Cylene Pharmaceuticals to create the right verbal and visual brand.  The new brand image was launched on a newly developed website.  The agency leveraged traditional public relations surrounding clinical trial results and key presentations and SMNRs to double the traffic to the company’s new website.